Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: A population-based observational study
Calvin Ke(Chinese University of Hong Kong), Andrea O. Y. Luk(Chinese University of Hong Kong), Elaine Chow(Chinese University of Hong Kong), Alice P.S. Kong(Chinese University of Hong Kong), Eric S. H. Lau(Chinese University of Hong Kong), Baiju R. Shah(Sunnybrook Health Science Centre), Juliana C.N. Chan(Chinese University of Hong Kong), Ronald C.W.(Chinese University of Hong Kong), Wing‐Yee So(Chinese University of Hong Kong), Thérèse A. Stukel(University of Toronto)
Cited by 64
Related Papers
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility
|Nature Genetics|2014|1.1k
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
|Nature Genetics|2007|1.1k
Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States
|Annals of the New York Academy of Sciences|2013|813
The global burden of metabolic disease: Data from 2000 to 2019
|Cell Metabolism|2023|777